No 0 2 0 2 O
evidence 3 11 3 11 O
of 12 14 12 14 O
active 15 21 15 21 O
/ 22 23 22 23 O
recurrent 24 33 24 33 O
disease 34 41 34 41 O
within 42 48 42 48 O
5 49 50 49 50 B-upper_bound
years 51 56 51 56 I-upper_bound

Patient 0 7 57 64 O
is 8 10 65 67 O
being 11 16 68 73 O
considered 17 27 74 84 O
for 28 31 85 88 O
SBRT 32 36 89 93 B-treatment

Patient 0 7 94 101 O
must 8 12 102 106 O
have 13 17 107 111 O
proven 18 24 112 118 O
or 25 27 119 121 O
suspected 28 37 122 131 O
non 38 41 132 135 B-cancer
small 42 47 136 141 I-cancer
cell 48 52 142 146 I-cancer
lung 53 57 147 151 I-cancer
cancer 58 64 152 158 I-cancer
( 65 66 159 160 I-cancer
NSCLC 66 71 160 165 I-cancer
) 71 72 165 166 I-cancer
and 73 76 167 170 O
be 77 79 171 173 O
clinical 80 88 174 182 O
Stage 89 94 183 188 B-lower_bound
I 95 96 189 190 I-lower_bound
or 97 99 191 193 O
IIa 100 103 194 197 B-upper_bound
, 103 104 197 198 O
according 105 114 199 208 O
to 115 117 209 211 O
the 118 121 212 215 O
7th 122 125 216 219 O
edition 126 133 220 227 O
staging 134 141 228 235 O
system 142 148 236 242 O
of 149 151 243 245 O
the 152 155 246 249 O
American 156 164 250 258 O
Joint 165 170 259 264 O
Commission 171 181 265 275 O
on 182 184 276 278 O
Cancer 185 191 279 285 O
for 192 195 286 289 O
lung 196 200 290 294 O
cancer 201 207 295 301 O
( 208 209 302 303 O
T1or 209 213 303 307 O
T2a 214 217 308 311 O
, 217 218 311 312 O
N0 219 221 313 315 O
or 222 224 316 318 O
N1 225 227 319 321 O
, 227 228 321 322 O
M0 229 231 323 325 O
) 231 232 325 326 O

Patients 0 8 327 335 O
already 9 16 336 343 O
scheduled 17 26 344 353 O
to 27 29 354 356 O
receive 30 37 357 364 O
conventional 38 50 365 377 B-treatment
radiotherapy 51 63 378 390 I-treatment
, 63 64 390 391 O
chemotherapy 65 77 392 404 B-treatment
, 77 78 404 405 O
biological 79 89 406 416 B-treatment
therapy 90 97 417 424 I-treatment
, 97 98 424 425 O
vaccine 99 106 426 433 B-treatment
therapy 107 114 434 441 I-treatment
, 114 115 441 442 O
or 116 118 443 445 O
surgery 119 126 446 453 B-treatment
as 127 129 454 456 O
treatment 130 139 457 466 O

Patients 0 8 467 475 O
malignancy 9 19 476 486 B-cancer
is 20 22 487 489 O
consistent 23 33 490 500 O
with 34 38 501 505 O
well 39 43 506 510 O
differentiated 44 58 511 525 O
neuroendocrine 59 73 526 540 O
( 74 75 541 542 O
carcinoid 75 84 542 551 O
) 84 85 551 552 O
histology 86 95 553 562 O

